» Articles » PMID: 23363978

Binge Drinking Induces Whole-body Insulin Resistance by Impairing Hypothalamic Insulin Action

Overview
Journal Sci Transl Med
Date 2013 Feb 1
PMID 23363978
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals with a history of binge drinking have an increased risk of developing the metabolic syndrome and type 2 diabetes. Whether binge drinking impairs glucose homeostasis and insulin action is unknown. To test this, we treated Sprague-Dawley rats daily with alcohol (3 g/kg) for three consecutive days to simulate human binge drinking and found that these rats developed and exhibited insulin resistance even after blood alcohol concentrations had become undetectable. The animals were resistant to insulin for up to 54 hours after the last dose of ethanol, chiefly a result of impaired hepatic and adipose tissue insulin action. Because insulin regulates hepatic glucose production and white adipose tissue lipolysis, in part through signaling in the central nervous system, we tested whether binge drinking impaired brain control of nutrient partitioning. Rats that had consumed alcohol exhibited impaired hypothalamic insulin action, defined as the ability of insulin infused into the mediobasal hypothalamus to suppress hepatic glucose production and white adipose tissue lipolysis. Insulin signaling in the hypothalamus, as assessed by insulin receptor and AKT phosphorylation, decreased after binge drinking. Quantitative polymerase chain reaction showed increased hypothalamic inflammation and expression of protein tyrosine phosphatase 1B (PTP1B), a negative regulator of insulin signaling. Intracerebroventricular infusion of CPT-157633, a small-molecule inhibitor of PTP1B, prevented binge drinking-induced glucose intolerance. These results show that, in rats, binge drinking induces systemic insulin resistance by impairing hypothalamic insulin action and that this effect can be prevented by inhibition of brain PTP1B.

Citing Articles

Impact of binge drinking on alcoholic liver disease.

Kang J, Park S, Khanam M, Park S, Shin S, Seo W Arch Pharm Res. 2025; .

PMID: 40035998 DOI: 10.1007/s12272-025-01537-1.


Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies.

Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G Alcohol Clin Exp Res (Hoboken). 2024; 48(12):2222-2241.

PMID: 39581746 PMC: 11629438. DOI: 10.1111/acer.15493.


Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation.

Fehsel K Biomedicines. 2024; 12(10).

PMID: 39457607 PMC: 11505606. DOI: 10.3390/biomedicines12102294.


Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity.

Sakamoto K, Butera M, Zhou C, Maurizi G, Chen B, Ling L Cell Metab. 2024; 37(1):121-137.e6.

PMID: 39437790 PMC: 11711004. DOI: 10.1016/j.cmet.2024.09.012.


Lifetime alcohol consumption patterns and young-onset breast cancer by subtype among Non-Hispanic Black and White women in the Young Women's Health History Study.

Hirko K, Lucas D, Pathak D, Hamilton A, Post L, Ihenacho U Cancer Causes Control. 2023; 35(2):377-391.

PMID: 37787924 DOI: 10.1007/s10552-023-01801-z.


References
1.
Kipfer-Coudreau S, Eberle D, Sahbatou M, Bonhomme A, Guy-Grand B, Froguel P . Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia. 2004; 47(7):1278-1284. DOI: 10.1007/s00125-004-1432-5. View

2.
Oh-I S, Thaler J, Ogimoto K, Wisse B, Morton G, Schwartz M . Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am J Physiol Endocrinol Metab. 2010; 299(1):E47-53. PMC: 2904047. DOI: 10.1152/ajpendo.00026.2010. View

3.
Quintana D, McGregor I, Guastella A, Malhi G, Kemp A . A meta-analysis on the impact of alcohol dependence on short-term resting-state heart rate variability: implications for cardiovascular risk. Alcohol Clin Exp Res. 2012; 37 Suppl 1:E23-9. DOI: 10.1111/j.1530-0277.2012.01913.x. View

4.
Zabolotny J, Haj F, Kim Y, Kim H, Shulman G, Kim J . Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem. 2004; 279(23):24844-51. DOI: 10.1074/jbc.M310688200. View

5.
Stumvoll M, Jacob S . Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes. 1999; 107(2):107-10. DOI: 10.1055/s-0029-1212083. View